Kris Kowdley, MD, Velocity PI, Lead Author of Article Published in The Lancet Gastroenterology & Hepatology

Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, was the lead author of an article recently published in The Lancet Gastroenterology & Hepatology. Dr. Kowdley and team conducted a Phase 2 trial investigating the efficacy of rusfertide in treating HFE-related haemochromatosis (an inherited iron overload disorder caused by insufficient hepcidin production). Rusfertide prevented iron re-accumulation in the absence of phlebotomies and could be a viable therapeutic option for some patients with haemochromatosis.

Read the full study in The Lancet Gastroenterology & Hepatology:

Posted in

Quality. Continuity. Velocity.